87 related articles for article (PubMed ID: 2730035)
1. [Malignant lymphoma].
Shirakawa S; Kobayashi T; Kita K; Ohno T; Miwa H
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):951-8. PubMed ID: 2730035
[TBL] [Abstract][Full Text] [Related]
2. [A new system of diagnosis and classification--malignant lymphoma].
Shirakawa S; Kita K; Ohno T; Miwa H
Nihon Rinsho; 1992 Jun; 50(6):1200-8. PubMed ID: 1518135
[TBL] [Abstract][Full Text] [Related]
3. [Recent progress in the treatment of malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
[TBL] [Abstract][Full Text] [Related]
4. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
[TBL] [Abstract][Full Text] [Related]
5. [A progress in the diagnosis of malignant lymphoma].
Shirakawa S; Kita K; Ohno T; Miwa K
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1140-50. PubMed ID: 8031154
[TBL] [Abstract][Full Text] [Related]
6. [Recent progress in the treatment of malignant lymphoma].
Tobinai K; Shimoyama M
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1151-6. PubMed ID: 8031155
[TBL] [Abstract][Full Text] [Related]
7. Analysis of T-cell receptor and immunoglobulin gene rearrangements in the diagnosis of Hodgkin's and non-Hodgkin's lymphoma.
Gledhill S; Krajewski AS; Dewar AE; Onions DE; Jarrett RF
J Pathol; 1990 Jul; 161(3):245-54. PubMed ID: 2391586
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy for malignant lymphoma in Western countries and Japan].
Tobinai K
Gan To Kagaku Ryoho; 1993 Dec; 20(16):2472-7. PubMed ID: 8279844
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
11. Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital.
Sukpanichnant S; Sonakul D; Piankijagum A; Wanachiwanawin W; Veerakul G; Mahasandana C; Tanphaichitr VS; Suvatte V
Cancer; 1998 Sep; 83(6):1197-204. PubMed ID: 9740086
[TBL] [Abstract][Full Text] [Related]
12. [Recent progress in the chemotherapy of malignant lymphoma].
Tobinai K
Gan To Kagaku Ryoho; 1995 Mar; 22(4):437-43. PubMed ID: 7887635
[TBL] [Abstract][Full Text] [Related]
13. [Cases of familial leukemia-lymphoma in Szabolcs-Szatmár-Bereg County].
Jakó J; Szerafin L; Póth I; Nagy P; Smanykó D; Babicz T
Orv Hetil; 1992 Jan; 133(3):147-8, 153. PubMed ID: 1734343
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
[TBL] [Abstract][Full Text] [Related]
15. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
16. [A review of childhood cases of malignant lymphoma in Osaka, Japan].
Ohsawa M; Matsumoto M; Aozasa K; Tamai M; Tsujimura S; Kohro T
Gan No Rinsho; 1989 Apr; 35(5):609-13. PubMed ID: 2716191
[TBL] [Abstract][Full Text] [Related]
17. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
19. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors.
Caballero MD; Rubio V; Rifon J; Heras I; García-Sanz R; Vázquez L; Vidriales B; del Cañizo MC; Corral M; Gonzalez M; León A; Jean-Paul E; Rocha E; Moraleda JM; San Miguel JF
Bone Marrow Transplant; 1997 Sep; 20(6):451-8. PubMed ID: 9313877
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
